LEHIGH VALLEY, Pa.--(BUSINESS WIRE)--Uni-flo2 Single-nasal Cannula System, a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the dual-pronged cannula but with half the skin contact, reports increased consumer demand for the device which provides greater comfort, safety, freedom of movement and enhanced personal appearance. With industry adoption of this discreet, lightweight single cannula that optimizes oxygen absorption, improves health and enhances quality of life for patients needing low flow supplemental oxygen, Uni-flo2 represents significant market and revenue opportunities for medical device distributors and bulk purchasers serving multiple healthcare segments: in-home, outpatient or extended care settings, transport and hospital or hospice environments, as well as oxygen therapy suppliers and retailers.
“Distributors seeking an innovative product, competitive differentiation and expanded market share can now offer this high value product, a complete redesign of the traditional device which represents the first substantive improvement in decades for the delivery of oxygen via nasal cannula,” says Campbell Cauthen, Registered Respiratory Therapist and co-founder, UPODS LLC, developers and marketers of Uni-flo2. “Currently manufactured in the U.S. by an FDA-registered facility with durable, high quality materials that ensure longer use, the Uni-flo2 soft design eliminates skin irritation, promotes ease of movement, improves sleeping and eating, and enhances personal appearance.”
Designed for comfort and safety, the Uni-flo2 Single Nasal Cannula System conforms to facial contours, thereby eliminating chafing, facial or neck abrasion and reducing the chance of infection. Interchangeable to either nostril with multiple strain-relief positions that ensure gas flow, Uni-flo2 reduces tube tugging or pulling on the patient. Uni-flo2 is designed to deliver up to six liters per minute of supplemental oxygen to adults.
“Uni-flo2 is not only cosmetically appealing and more comfortable, but also offers more efficient oxygen delivery, with the potential to reduce oxygen costs over time,” explains Cauthen. “It’s no wonder that patient satisfaction surveys are so positive, with 98 percent finding it more comfortable, stable and secure. Many hardly know they are wearing a cannula.”
Uni-flo2 offers distributors value-added services, including patient/caregiver support and education, volume discounts, special considerations and expedited order fulfillment. UPODS Uni-flo2 Nasal Cannulas assigned HCPCS Codes for DME Billing; PS-1004, PS-1007 HCPCS Code A4615. Contact: 610.924.7949; firstname.lastname@example.org.
Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous oxygen flow equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348. Visit www.uniflo2.com